April 27 (Reuters) - Sobi CEO at Q1 earnings call:
* CEO, asked about interest in Biogen's hemophilia assets, says "this is not a time to bet the company on something that is at the outer limits of our capacity"
* Says focused on transactions that allow us to absorb, integrate them in a way that doesn't distract us
* Says for me, means size within reach of current debt capacity and maybe to lesser degree the use of equity
* Sources told Reuters earlier this month Biogen is exploring a sale of hemophilia assets Further company coverage: